Ujvira 160mg Injection
By Ujvira
Rx
1 Injection in a Vial

Composition
Trastuzumab(160mg)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
October, 2025

liver
Limited information is currently available regarding the use of Ujvira 160mg Injection in patients with liver disease. It is advised to consult with your doctor for personalized guidance on the safety of using this injection if you have liver issues. Your healthcare provider is best equipped to assess your individual situation and provide you with the most suitable advice. It is crucial to prioritize your liver health and take necessary precautions when considering the use of Ujvira 160mg Injection in such cases.

kidney
Ujvira 160mg Injection is likely safe for patients with kidney disease. Consult your doctor as dose adjustment may not be necessary based on limited data available.

alcohol
When using Ujvira 160mg Injection, be mindful that it can lead to increased drowsiness when consuming alcohol.

driving
It is uncertain if Ujvira 160mg Injection affects driving ability. Avoid driving if you have symptoms that hinder focus and reaction time.

pregnancy
Ujvira 160mg Injection is considered unsafe during pregnancy due to the risk to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor.

breastfeeding
Caution should be taken while breastfeeding and using Ujvira 160mg Injection. Limited human data indicates potential harm to the baby due to drug passage into breastmilk. It is advisable to consult your doctor.
Habit Forming | No |
Chemical Class | Monoclonal Antibody |
Therapeutic Class | - |
Action Class | HER2/neu (ErbB2) Inhibitor- Monoclonal antibody |
₹49995
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025